In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dimension Therapeutics Inc.

Division of Ultragenyx Pharmaceutical Inc.
www.dimensiontx.com

Latest From Dimension Therapeutics Inc.

Interview: Silence Therapeutics’ Chair On Why Keeping Quiet Has Done The Biotech No Favors

Silence Therapeutics’ executive chair, Annalisa Jenkins, talks to Scrip about why there’s more to the company than a court case.

Commercial Leadership

Biopharma Quarterly Dealmaking Statistics, Q3 2017

Third-quarter biopharma financing, which totaled $12.5 billion, was dominated by follow-on public offerings, which represented virtually half the value. Acquisition activity was headlined by a major move by Gilead in the CART market. Five alliances were signed worth over $1 billion, led by a partnership between two key players, Merck & Co. and AstraZeneca.

BioPharmaceutical Deals

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ultragenyx Pharmaceutical Inc.
  • Senior Management
  • Annalisa Jenkins, CEO
    Sam Wadsworth, PhD, CSO
    Andy Hu, MD, Head, Bus. Dev.
    Mary Thistle, COO
    K. Reed Clark, PhD, SVP, Head, Pharmaceutical Dev.
    Eric Crombez, MD, CMO
    Alex Fotopoulos, MSc, SVP, Head Tech Ops.
    Robert Gaffey, VP, Finance
    Janet Rae, Head, Global Reg Affairs
    Khandan Baradaran, PhD, Head of Quality
  • Contact Info
  • Dimension Therapeutics Inc.
    Phone: (617) 401-0011
    840 Memorial Dr.
    4th Fl.
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register